Patient Preference for Dosing Frequency Based on Prior Biologic Experience.

Zhang, Mingliang; Carter, Chureen; Olson, William H; Johnson, Michael P; Brennem, Susan K; Lee, Seina; Farahi, Kamyar

Zhang, Mingliang; Carter, Chureen; Olson, William H; Johnson, Michael P; Brennem, Susan K; Lee, Seina; Farahi, Kamyar.

J Drugs Dermatol ; 16(3): 220-226, 2017 Mar 01.

Article in En | MEDLINE | ID: mdl-28301617

Subject(s)

Biological Products/administration & dosage; Biological Products/therapeutic use; Patient Preference/statistics & numerical data; Psoriasis/drug therapy; Adalimumab/administration & dosage; Adalimumab/therapeutic use; Cross-Sectional Studies; Decision Making; Drug Administration Schedule; Etanercept/administration & dosage; Etanercept/therapeutic use; Humans; Middle Aged; Severity of Illness Index; Surveys and Questionnaires; Ustekinumab/administration & dosage; Ustekinumab/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Biological Products / Patient Preference Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans / Middle aged Language: En Journal: J Drugs Dermatol Journal subject: DERMATOLOGIA Year: 2017 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links